BridgeMD
New treatment option for Autism Spectrum Disorder
Official title Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder
ClinicalTrials.gov ID: NCT06006637
What this study is testing
- What it's testing
- This study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University and Mt. Sinai Medical Center with 80 autistic children evaluating the effects of transcranial photobiomodulation (tPBM) on multiple clinically validated scales.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 8
You may be able to join if
- Ages 2 - 8
- Autism spectrum disorder diagnosis
- CARS-2 score of 30 - 45
You likely can't join if
- CARS scores less than 30 or over 45.
- Taking psychotropic medications.
- Having skin lesions on scalp
- Having history of seizures
- Having history of abnormal EEG
- Being a relative of the PI or a researcher
See the full eligibility criteria
- Ages 2 - 8
- Autism spectrum disorder diagnosis
- CARS-2 score of 30 - 45
- CARS scores less than 30 or over 45.
- Taking psychotropic medications.
- Having skin lesions on scalp
- Having history of seizures
- Having history of abnormal EEG
- Being a relative of the PI or a researcher
- Having implanted devices (including cochlear implants).
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
- Syracuse, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 years to 8 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States; Syracuse, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.